As of Jan 19
| 0.00 / 0.00%|
The 24 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 53.17, with a high estimate of 64.60 and a low estimate of 47.00. The median estimate represents a -4.62% decrease from the last price of 55.75.
The current consensus among 27 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.